Article
U.S. FDA approves Sanofi's bleeding disorder therapy
Rating:
0.0
Views:
62
Likes:
1
Library:
1
The U.S. Food and Drug Administration has approved Sanofi SA's therapy to treat a type of inherited bleeding disorder known as hemophilia A and expects to launch it in the United States in April, the French drugmaker said on Thursday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value